rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-2-8
|
pubmed:abstractText |
The inability of radiotherapy to eradicate completely certain human tumours may be due to the presence of resistant hypoxic cells. Several studies have confirmed the radiosensitizing effect of paclitaxel, a microtubular inhibitor. The object of this study was to evaluate the physicochemical characteristics of paclitaxel-loaded nanoparticles, and determine the ability of the released paclitaxel to radiosensitize hypoxic human breast carcinoma cells (MCF-7) with respect to radiation dose.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0269-4727
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
41-7
|
pubmed:dateRevised |
2008-5-28
|
pubmed:meshHeading |
pubmed-meshheading:17286788-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:17286788-Breast Neoplasms,
pubmed-meshheading:17286788-Cell Line, Tumor,
pubmed-meshheading:17286788-Combined Modality Therapy,
pubmed-meshheading:17286788-Delayed-Action Preparations,
pubmed-meshheading:17286788-Drug Carriers,
pubmed-meshheading:17286788-Humans,
pubmed-meshheading:17286788-Lactic Acid,
pubmed-meshheading:17286788-Nanoparticles,
pubmed-meshheading:17286788-Paclitaxel,
pubmed-meshheading:17286788-Particle Size,
pubmed-meshheading:17286788-Polyglycolic Acid,
pubmed-meshheading:17286788-Polymers
|
pubmed:year |
2007
|
pubmed:articleTitle |
The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells.
|
pubmed:affiliation |
Department of Radiation Medicine, Fourth Military Medical University, Xi'an, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|